ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
HilleVax Inc

HilleVax Inc (HLVX)

1.86
0.04
(2.20%)
마감 24 11월 6:00AM
1.855
-0.005
(-0.27%)
시간외 거래: 9:59AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
1.86
매수가
1.76
매도가
1.91
거래량
126,535
1.83 일간 변동폭 1.90
1.55 52주 범위 20.22
market_cap
전일 종가
1.82
개장가
1.84
최근 거래 시간
1
@
1.86
마지막 거래 시간
재정 규모
US$ 235,034
VWAP
1.8575
평균 볼륨(3m)
184,178
발행 주식
49,806,070
배당수익률
-
주가수익률
-0.75
주당순이익(EPS)
-2.48
매출
-
순이익
-123.57M

HilleVax Inc 정보

HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norov... HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
HilleVax Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker HLVX. The last closing price for HilleVax was US$1.82. Over the last year, HilleVax shares have traded in a share price range of US$ 1.55 to US$ 20.22.

HilleVax currently has 49,806,070 shares in issue. The market capitalisation of HilleVax is US$90.65 million. HilleVax has a price to earnings ratio (PE ratio) of -0.75.

HLVX 최신 뉴스

HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress

$189.3 million of cash, cash equivalents and marketable securities as of September 30, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in...

HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress

$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024 The company is exploring the potential for continued development of its HIL-214 and HIL-216 norovirus...

HilleVax Announces Reduction in Force

BOSTON, July 31, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced a...

HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants

The NEST-IN1 clinical study did not meet its primary or secondary efficacy endpoints, and the company will discontinue further development of HIL-214 in infants The company is exploring the...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.08-4.123711340211.941.941.781301711.82048545CS
40.031.63934426231.832.0151.781346901.88779594CS
12-0.03-1.58730158731.892.0151.681841781.82275354CS
26-12.58-87.119113573414.4415.61.556411782.54386912CS
52-12.08-86.657101865113.9420.221.554017844.92298843CS
156-16.9-90.085287846518.7624.421.552118317.56908837CS
260-16.9-90.085287846518.7624.421.552118317.56908837CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
PDYNPalladyne AI Corporation
US$ 4.59
(129.50%)
83M
QMCOQuantum Corporation
US$ 9.11
(126.62%)
39.41M
NANano Labs Ltd
US$ 8.26
(89.02%)
2.03M
XCURExicure Inc
US$ 18.60
(71.27%)
4.36M
SKKSKK Holdings Limited
US$ 1.75
(59.09%)
95.06M
AMIXAutonomix Medical Inc
US$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
US$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
US$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
US$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
US$ 0.0201
(-0.50%)
415.87M
NVDANVIDIA Corporation
US$ 141.95
(-3.22%)
229.93M
SMCISuper Micro Computer Inc
US$ 33.15
(11.62%)
155.43M
VRPXVirpax Pharmaceuticals Inc
US$ 0.5501
(-6.72%)
154.17M
SOUNSoundHound AI Inc
US$ 8.24
(18.05%)
103.6M

최근 히스토리

Delayed Upgrade Clock